Matches in Wikidata for { <http://www.wikidata.org/entity/Q92609235> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q92609235 description "article scientifique publié en 2020" @default.
- Q92609235 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92609235 description "scientific article published on 13 January 2020" @default.
- Q92609235 description "wetenschappelijk artikel" @default.
- Q92609235 description "наукова стаття, опублікована 13 січня 2020" @default.
- Q92609235 name "Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy" @default.
- Q92609235 name "Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy" @default.
- Q92609235 type Item @default.
- Q92609235 label "Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy" @default.
- Q92609235 label "Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy" @default.
- Q92609235 prefLabel "Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy" @default.
- Q92609235 prefLabel "Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy" @default.
- Q92609235 P1433 Q92609235-CAB81A30-868C-449B-8E09-9FFB75C8521F @default.
- Q92609235 P1476 Q92609235-62A1DEEA-6DBA-46B4-851A-776C249E3822 @default.
- Q92609235 P2093 Q92609235-2B7E7DE7-2999-4D17-AA14-E4B453CBDF02 @default.
- Q92609235 P2093 Q92609235-4BDA4591-8D19-42C0-8BA4-B582ABCB6659 @default.
- Q92609235 P2093 Q92609235-4FB54C5E-BE5C-444B-A7AE-7ADAE22B21A4 @default.
- Q92609235 P2093 Q92609235-713EFA6E-FE3D-4B75-B6C9-0236A67F1E81 @default.
- Q92609235 P2093 Q92609235-88495937-BA71-4C18-A90E-356A810F9600 @default.
- Q92609235 P2093 Q92609235-9E34C4B1-929D-434E-A358-C728D1E528FA @default.
- Q92609235 P2093 Q92609235-E6AE296A-CFC7-43FD-92FC-B66FE3C35637 @default.
- Q92609235 P31 Q92609235-9B1236AD-2B4B-464D-B91C-5129DA541E9B @default.
- Q92609235 P356 Q92609235-2A21AB3F-947D-4B68-B18F-2BA4DF9F782F @default.
- Q92609235 P577 Q92609235-D9C1235C-B435-4589-B2E0-6E531BAD6888 @default.
- Q92609235 P698 Q92609235-7A7CD105-3A9F-4B5A-80BB-94F5638287B2 @default.
- Q92609235 P932 Q92609235-78F2AFE3-B5F0-4AF5-94C4-C9F99977C270 @default.
- Q92609235 P356 WNL.0000000000008944 @default.
- Q92609235 P698 31932515 @default.
- Q92609235 P1433 Q1161692 @default.
- Q92609235 P1476 "Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy" @default.
- Q92609235 P2093 "Charles M Conway" @default.
- Q92609235 P2093 "David Kudrow" @default.
- Q92609235 P2093 "Kathleen Mullin" @default.
- Q92609235 P2093 "Meghan Lovegren" @default.
- Q92609235 P2093 "Richard B Lipton" @default.
- Q92609235 P2093 "Robert Croop" @default.
- Q92609235 P2093 "Vladimir Coric" @default.
- Q92609235 P31 Q13442814 @default.
- Q92609235 P356 "10.1212/WNL.0000000000008944" @default.
- Q92609235 P577 "2020-01-13T00:00:00Z" @default.
- Q92609235 P698 "31932515" @default.
- Q92609235 P932 "7526667" @default.